Fusion proteins of interferon alpha muteins with improved properties

Details for Australian Patent Application No. 2004213565 (hide)

Owner Merck Patent GmbH

Inventors Hanlon, Marian; Baker, Matthew; Jones, Tim; Carr, Francis Joseph

Agent Davies Collison Cave

Pub. Number AU-A-2004213565

PCT Pub. Number WO2004/074486

Priority 03003647.9 18.02.03 EP

Filing date 18 February 2004

Wipo publication date 2 September 2004

International Classifications

C12N 015/21 Mutation or genetic engineering

C07K 014/56 Peptides having more than 20 amino acids

A61K 038/21 Medicinal preparations containing peptides - Interferons

Event Publications

6 October 2005 PCT application entered the National Phase

  PCT publication WO2004/074486 Priority application(s): WO2004/074486

10 May 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004213566-Inactivated nodavirus vaccine

2004213554-Expression in plants of antibodies against enterotoxigenic escherichia coli